Cash · 2017–2025
Twist Bioscience cash
$149M−32.9% · FY2025
Twist Bioscience (TWST) reported $149M in cash for fiscal 2025, −32.9% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $149M | −32.9% | Open → |
| FY20242024-12-31 | $221M | −16.8% | Open → |
| FY20232023-12-31 | $266M | −15.9% | Open → |
| FY20222022-12-31 | $317M | +65.3% | Open → |
| FY20212021-12-31 | $192M | −45.1% | Open → |
| FY20202020-12-31 | $349M | +1,239.8% | Open → |
| FY20192019-12-31 | $26.0M | −60.8% | Open → |
| FY20182018-12-31 | $66.5M | +152.8% | Open → |
| FY20172017-12-31 | $26.3M | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2017–2025 compound annual growth +24.2%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Twist Bioscience cash |url=https://companiesranked.com/en/company/twist-bioscience/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Twist Bioscience cash. CompaniesRanked. https://companiesranked.com/en/company/twist-bioscience/cash-on-handBibTeX
@misc{companiesranked-en-company-twist-bioscience-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Twist Bioscience cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/twist-bioscience/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.